Aqua Bio Technology - Regulatory Filings 2023

Market update Aqua Bio Technology ASA (ABT) - US patent for the ingredient Chaga

3.3.2023 15:44:45 CET | Aqua Bio Technology ASA | Non-regulatory press releases

ABT has been granted a US patent for use of Chaga in cosmetic formulation. The

Chaga mushroom grows on birch trees throughout the northern hemisphere. The

extract from Chagas mushroom has shown good results on wrinkles and general skin

improvement. The extract from Chagas mushroom can be beneficial for anyone

suffering from skin conditions such as acne, allergic reactions, rashes,

dermatitis, psoriasis, rosacea and eczema. The US patent secures ABT's use of

this ingredient in existing and future cosmetic products and prohibits other

players to use this ingredient without a specific license from ABT.

Co-location:

From 1 March 2023, Hofseth Biocare ASA, Cosmed Beauty AS and Aqua Bio Technology

ASA are co-located in Bygdøy Alle 3 in Oslo. The co-location will lead to

increased synergies between the companies that all have the same main

shareholder.

DISCLOSURE REGULATION

This information is subject of the disclosure requirements pursuant to section

of 5-12 of the Norwegian Securities Trading Act.

CONTACTS

* Håvard Lindstrøm, 004794132288, [email protected]

ABOUT AQUA BIO TECHNOLOGY ASA

Aqua Bio Technology (ABT) is developing and commercializing sustainable

biotechnology for use in skin care products. ABT's cosmetics ingredients are

highly effective and they provide the cosmetics industry with natural

alternatives to traditional ingredients. ABT is also marketing and distributing

natural skin care products developed by partners towards consumers and

professional users. Aqua Bio Technology is listed on Euronext Expand.

ATTACHMENTS

Download announcement as PDF.pdf -

https://kommunikasjon.ntb.no/ir-files/17847556/2156/2900/Download%20announcement

%20as%20PDF.pdf

AI assistant